U-Systems, a developer and marketer of breast ultrasound systems, has announced its plans to conduct a multi-center breast cancer screening study named somoInSIGHT, with more than 20,000 women, using its proprietary automated breast ultrasound system.
Subscribe to our email newsletter
The clinical study will evaluate the sensitivity and specificity of X-ray mammography (XRM) and automated breast ultrasound system (ABUS) together, as compared to XRM alone, as a breast cancer screening method in women with greater than 50% parenchymal density.
Bob Foley, U-System’s vice president of clinical affairs, said: “We are initiating this multi-center study with our somov to address that population of women with dense breasts. This is an undertaking that U-Systems feels is vital in the battle to find cancers earlier and at a more curable stage.
“We believe that the somoInSIGHT study will demonstrate that screening dense breasted patients with ABUS and XRM is more beneficial than XRM alone.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.